Ann Kjellstedt

AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats

Bengt Ljung, Krister Bamberg, Björn Dahllöf et al. · Journal of Lipid Research · 2002 · 110 citations · Full text

Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer

Nicholas D. Oakes, Ann Kjellstedt, Gun‐Britt Forsberg et al. · Journal of Lipid Research · 1999 · 53 citations · Full text

Activation of β₃-adrenoceptors increases in vivo free fatty acid uptake and utilization in brown but not white fat depots in high-fat-fed rats

Amy Warner, Ann Kjellstedt, Alba Carreras et al. · American Journal of Physiology-Endocrinology and Metabolism · 2016 · 45 citations · Full text

Vascular Versus Myocardial Selectivity of Calcium Antagonists Studied by Concentration-Time-Effect Relations

Bengt Ljung, Ann Kjellstedt, Bengt Orebäck · Journal of Cardiovascular Pharmacology · 1987 · 26 citations

Heart Failure, Calcium Antagonists Studied, Concentration-time-effect Relations +17

The PPAR<b><i>α</i></b>/<b><i>γ</i></b>Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization<i>In Vivo</i>in the Obese Zucker Rat

Kristina Wallenius, Ann Kjellstedt, Pia Thalén et al. · PPAR Research · 2013 · 22 citations · Full text